Literature DB >> 5080765

In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.

M Jurin, H D Suit.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5080765

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  Thymic factor-induced reduction of pulmonary metastases in mice with FSA-1 fibrosarcoma.

Authors:  V J Tomazic; C R Sacasa; A Loftus; C S Suter; G E Elias
Journal:  Clin Exp Metastasis       Date:  1988 Jan-Feb       Impact factor: 5.150

2.  Tumorigenic cell culture lines from a spontaneous VM/Dk murine astrocytoma (SMA).

Authors:  R D Serano; C N Pegram; D D Bigner
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

3.  Natural history of mouse syngeneic lymphoma. Morphologic and immunologic aspects.

Authors:  M Jurin; B Drewinko
Journal:  Am J Pathol       Date:  1974-11       Impact factor: 4.307

Review 4.  A Century of Radiation Therapy and Adaptive Immunity.

Authors:  Dörthe Schaue
Journal:  Front Immunol       Date:  2017-04-11       Impact factor: 7.561

Review 5.  A perspective on the impact of radiation therapy on the immune rheostat.

Authors:  William H McBride; Ekambaram Ganapathy; Mi-Heon Lee; Jean P Nesseler; Christine Nguyen; Dörthe Schaue
Journal:  Br J Radiol       Date:  2017-07-14       Impact factor: 3.039

Review 6.  Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response.

Authors:  Roger Gilabert-Oriol; Gemma M Ryan; Ada W Y Leung; Natalie S Firmino; Kevin L Bennewith; Marcel B Bally
Journal:  Int J Mol Sci       Date:  2018-09-26       Impact factor: 5.923

7.  The role of regulatory T lymphocytes in immune control of MC-2 fibrosarcoma.

Authors:  Tomislav Jukić; Ana Jurin Martić; Siniša Ivanković; Mariastefania Antica; Doroteja Pavan Jukić; Cecilija Rotim; Mislav Jurin
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.